Publications by authors named "Heather H Cheng"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

180

Total Likes

143

Extended Reach

529,570

Social Features

69
P
Phase II Study of Erdafitinib in Patients With Tumors With Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane

JCO Precis Oncol· April 2024

Videos about Article: user

1 33

View All Article and Social Media Activity
P
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane

JCO Precis Oncol· April 2024

Videos about Article: user

1 29

View All Article and Social Media Activity
T
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
Stacy Loeb, Scott W Keith, Heather H Cheng, Amy E Leader, Laura Gross, Tatiana Sanchez Nolasco, Nataliya Byrne, Rebecca Hartman, Lauren H Brown, Christopher Michael Pieczonka

JCO Precis Oncol· March 2024

Videos about Article: user

1 4 2

View All Article and Social Media Activity
A
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study.
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, Leonidas Ν Diamantopoulos, Dimitrios Makrakis, Heather H Cheng

Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial.
Gerhardt Attard, Neeraj Agarwal, Julie N Graff, Shahneen Sandhu, Eleni Efstathiou, Heather H Cheng

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations.
Heather H Cheng, Sam Callis, Evan Y Yu, Scott E Delacroix, Alexandra O Sokolova

Eur Urol Focus· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.
Daniel E Spratt, Sandy Srinivas, Nabil Adra, Bilawal Ahmed, Yi An, Heather H Cheng

J Natl Compr Canc Netw· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance.
Matthew R Cooperberg, John R Bihn, John M Culnan, Jennifer La, Sergey D Goryachev, Heather H Cheng

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry.
Stacy Loeb, Scott W Keith, Laura Gross, Rebecca L Hartman, Tomasz M Beer, Heather H Cheng

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer.
Martine P Roudier, Roman Gulati, Erolcan Sayar, Radhika A Patel, Micah Tratt, Heather H Cheng

J Clin Invest· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies.
Hyun Jung Lee, Roman Gulati, Erolcan Sayar, Radhika A Patel, Pushpa Itagi, Heather H Cheng

Cancer Res Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer.
Francesca Zacchi, Wassim Abida, Emmanuel S Antonarakis, Alan H Bryce, Elena Castro, Heather H Cheng

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair Deficiency.
Ruben Raychaudhuri, Heather H Cheng, Roman Gulati, Michael T Schweizer, Aaron Lin

Eur Urol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial.
Ruben Raychaudhuri, Makayla DeJong, Matthew Rettig, Evan Y Yu, Roman Gulati, Heather H Cheng

Eur Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
Silke Gillessen, Fabio Turco, Ian D Davis, Jason A Efstathiou, Karim Fizazi, Heather H Cheng

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline.
Evan Y Yu, R Bryan Rumble, Neeraj Agarwal, Heather H Cheng, Scott E Eggener

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes.
Ruben Raychaudhuri, Abuzar Moradi Tuchayi, Soon Khai Low, Ali T Arafa, Laura S Graham, Heather H Cheng

Eur Urol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review.
Edoardo Francini, Neeraj Agarwal, Elena Castro, Heather H Cheng, Kim N Chi

Eur Urol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received Lu-PSMA-617: Importance of F-FDG-Avid Discordant Findings.
Ridvan Arda Demirci, Alireza Ghodsi, Roman Gulati, Sanaz Behnia, Peter S Nelson, Heather H Cheng

J Nucl Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Lu-PSMA-617.
Ridvan Arda Demirci, Roman Gulati, Jessica E Hawley, Todd Yezefski, Michael C Haffner, Heather H Cheng

J Nucl Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide.
Mamta Parikh, Catherine Tangen, Maha H A Hussain, Shilpa Gupta, Sam Callis, Heather H Cheng

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.
Heather H Cheng, Jeffrey W Shevach, Elena Castro, Fergus J Couch, Susan M Domchek

JAMA Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.
Amy E Leader, Timothy R Rebbeck, William K Oh, Alpa V Patel, Eric P Winer, Heather H Cheng

BMC Public Health· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates.
Azra Ajkunic, Erolcan Sayar, Martine P Roudier, Radhika A Patel, Ilsa M Coleman, Heather H Cheng

NPJ Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to Lu-PSMA-617: A Retrospective Multicenter Cohort Study.
Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, Laura Graham, Roman Gulati, Heather H Cheng

JCO Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis